Rolf Ljung
51 – 60 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Pain and pain management in haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Tailoring care to haemophilia patients' needs: which specialty and when?
(
- Contribution to journal › Article
-
Mark
The current status of prophylactic replacement therapy in children and adults with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
(
- Contribution to journal › Letter
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
(
- Contribution to journal › Letter
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
(
- Contribution to journal › Scientific review
-
Mark
How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access
(
- Contribution to journal › Article
-
Mark
Rationale for individualizing haemophilia care.
(
- Contribution to journal › Scientific review